This is a multicenter, randomized, study to evaluate the safety, immunogenicity, and efficacy of VRC-ZKADNA090-00-VP (Zika virus wildtype DNA vaccine) or placebo. The primary objectives are to evaluate the safety and efficacy of the vaccine compared to placebo.
|Principal Investigator||Dynio Honrubia, MD|
|Sponsor||National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC)|
|Type of Trial||Interventional|